SCHEMBL16286346

SCHEMBL16286346

CC1(F)C=CC(N)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28609118 0.76
SCHEMBL5673793 0.76 NOS3 (0.33)
SCHEMBL11507660 0.76
SCHEMBL283760 0.74
SCHEMBL12806508 0.74
SCHEMBL33699 0.74
Hydrochloric Acid SCHEMBL7196448 0.73 NOS3 (0.31)
SCHEMBL13679854 0.73
SCHEMBL5386968 0.73
Hydrochloric Acid SCHEMBL7637452 0.73 NOS3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10676429-B2 Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B JANSSEN SCIENCES IRELAND UC (IE) 2020-06-09 US disclosed
EP-3114111-B1 BICYCLIC PYRROLE DERIVATIVES USEFUL AS AGONISTS OF GPR120 JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 EP disclosed
EP-3114111-A1 BICYCLIC PYRROLE DERIVATIVES USEFUL AS AGONISTS OF GPR120 Janssen Pharmaceutica NV (BE) 2017-01-11 EP disclosed
CN-106061943-A Bicyclic pyrrole derivatives useful as agonists of GPR120 詹森药业有限公司 2016-10-26 CN disclosed
US-20150266890-A1 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN SCIENCES IRELAND UC (IE) 2015-09-24 US disclosed
WO-2015134038-A1 BICYCLIC PYRROLE DERIVATIVES USEFUL AS AGONISTS OF GPR120 JANSSEN PHARMACEUTICA NV (BE) 2015-09-11 WO disclosed
US-8912227-B1 Bicyclic pyrrole derivatives useful as agonists of GPR120 JANSSEN PHARMACEUTICA NV (BE) 2014-12-16 US disclosed